Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 34

    1.

    Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer.

    Simpson GR, Horvath A, Annels NE, Pencavel T, Metcalf S, Seth R, Peschard P, Price T, Coffin RS, Mostafid H, Melcher AA, Harrington KJ, Pandha HS.

    Br J Cancer. 2012 Jan 31;106(3):496-507. doi: 10.1038/bjc.2011.577. Epub 2012 Jan 12.

    PMID:
    22240799
    [PubMed - indexed for MEDLINE]
    2.

    Open clinical uro-oncology trials in Canada.

    Winquist E, Rodrigues G.

    Can J Urol. 2011 Aug;18(4):5849-55. No abstract available.

    PMID:
    21854720
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Thermal injury causing delayed perforation of small bowel after transurethral resection of bladder tumor without evidence of bladder perforation.

    Abraham NE, Simon R, Shah O.

    Can J Urol. 2011 Aug;18(4):5836-8.

    PMID:
    21854717
    [PubMed - indexed for MEDLINE]
    4.

    Intravesical gemcitabine for non-muscle invasive bladder cancer.

    Jones G, Cleves A, Wilt TJ, Mason M, Kynaston HG, Shelley M.

    Cochrane Database Syst Rev. 2012 Jan 18;1:CD009294.

    PMID:
    22259002
    [PubMed - in process]
    5.

    Current world literature.

    [No authors listed]

    Curr Opin Urol. 2011 Sep;21(5):440-5. doi: 10.1097/MOU.0b013e32834a26cd. No abstract available.

    PMID:
    21814056
    [PubMed - indexed for MEDLINE]
    6.

    Treatment of uncommon malignant tumours of the bladder.

    Boyle H, Fléchon A, Droz JP.

    Curr Opin Urol. 2011 Sep;21(5):309-14. doi: 10.1097/MOU.0b013e3283495758. Review.

    PMID:
    21814051
    [PubMed - indexed for MEDLINE]
    7.

    High magnification cystoscopy in the primary diagnosis of bladder tumors.

    Jichlinski P, Lovisa B.

    Curr Opin Urol. 2011 Sep;21(5):398-402. doi: 10.1097/MOU.0b013e32834956ad. Review.

    PMID:
    21730856
    [PubMed - indexed for MEDLINE]
    8.

    Comment: analyses using time-dependent pioglitazone usage in Cox models may lead to wrong conclusions about its association with cancer.

    Yang X, Chan JC.

    Diabetes Care. 2011 Aug;34(8):e136; author reply 137. No abstract available.

    PMID:
    21788639
    [PubMed - indexed for MEDLINE]
    9.

    The Association Between -330T/G Polymorphism of Interleukin 2 Gene and Bladder Cancer.

    Shen Y, Liu Y, Liu S, Zhang A.

    DNA Cell Biol. 2012 Jan 13. [Epub ahead of print]

    PMID:
    22242968
    [PubMed - as supplied by publisher]
    10.

    Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A new and highly prognostic system to discern T1 bladder cancer substage. Eur Urol 2012;61:378-84.

    Burger M, Otto W, Hartmann A.

    Eur Urol. 2012 Apr;61(4):e31-2; author reply e33-4. Epub 2012 Jan 11. No abstract available.

    PMID:
    22245308
    [PubMed - in process]
    11.

    Error occurred: cannot get document summary

    PMID:
    22244777

    12.

    Urothelial carcinoma with multiple patterns of divergent differentiation featuring small cell, clear cell, papillary glandular and squamous cell morphology.

    Jain D, Dhawan S, Chopra P.

    Indian J Pathol Microbiol. 2011 Jul-Sep;54(3):651-2. No abstract available.

    PMID:
    21934256
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Laparoscopic radical cystectomy for bladder cancer with prostatic and neurovascular sparing: initial experience.

    Gou X, Wang M, He WY, Liu CD, Deng YZ, Ren K, Chen Y.

    Int Urol Nephrol. 2012 Jun;44(3):787-92. Epub 2012 Jan 17.

    PMID:
    22249369
    [PubMed - in process]
    14.

    Multiple primary cancers including mesothelioma of the tunica vaginalis: case report and literature review with primary care focus.

    Bass L, Hegeman TW.

    J Am Osteopath Assoc. 2011 Aug;111(8):483-6. Review.

    PMID:
    21862756
    [PubMed - indexed for MEDLINE]
    15.

    Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer.

    Gecit I, Aslan M, Gunes M, Pirincci N, Esen R, Demir H, Ceylan K.

    J Cancer Res Clin Oncol. 2012 May;138(5):739-43. Epub 2012 Jan 19.

    PMID:
    22258852
    [PubMed - in process]
    Free PMC Article
    16.

    Prostatic urethral recurrence of urachal adenocarcinoma.

    Ching CB, Chen L, Fergany A.

    J Clin Oncol. 2011 Oct 1;29(28):e736-8. Epub 2011 Sep 6. No abstract available.

    PMID:
    21900110
    [PubMed - indexed for MEDLINE]
    17.

    Bladder leiomyoma: a case report.

    Bera MK, Pal K.

    J Indian Med Assoc. 2011 Apr;109(4):272-3.

    PMID:
    22187802
    [PubMed - indexed for MEDLINE]
    18.

    Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure.

    Fernández MI, López JF, Vivaldi B, Coz F.

    J Urol. 2012 Mar;187(3):856-61. Epub 2012 Jan 15.

    PMID:
    22248521
    [PubMed - indexed for MEDLINE]
    19.

    Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trial.

    Kamat AM, Dickstein RJ, Messetti F, Anderson R, Pretzsch SM, Gonzalez GN, Katz RL, Khanna A, Zaidi T, Wu X, Grossman HB, Dinney CP.

    J Urol. 2012 Mar;187(3):862-7. Epub 2012 Jan 15.

    PMID:
    22245325
    [PubMed - indexed for MEDLINE]
    20.

    Electromotive administration of mitomycin.

    Ho CC.

    Lancet Oncol. 2011 Dec;12(13):1183. No abstract available.

    PMID:
    22123591
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk